NAGE vs PARA · P/E 59, rev $61.3M vs rev $5.0M
Niagen Bioscience, Inc. (NAGE) versus PARA (PARA) — a side-by-side from cached financials, not a winner call.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
PARA (PARA) common stock.
Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Latest reported PARA revenue for 2026-06-30 was $5.0M. Net income was -$13.4M. Revenue was up 84.3% from 2026-03-31 to 2026-06-30. PARA currently screens at market cap $0.
NAGE currently screens at market cap $836.5M and trailing P/E 59.0. PARA currently screens at market cap $0.
Not investment advice. Open the NAGE and PARA stock pages for the full models.
Not investment advice.